Evidence map›Paper›PMID 33931496›Full record

ArticleImmunoHorizons2021

Human Blood Plasma Shapes Distinct Neonatal TLR-Mediated Dendritic Cell Activation via Expression of the MicroRNA Let-7g.

Ross England, Jensen Pak, Mark Liu, Shun Rao, Al Ozonoff, Ofer Levy, Simon D van Haren

Open access · goldAbstract read
In one paragraph

Article in ImmunoHorizons, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Innovative micro physiological systems for vaccine development.Human vaccines & immunotherapeutics · 2025
    Review
  4. Vaccinology: Getting our modernization act together.The Journal of experimental medicine · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ross EnglandPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA.ORCID 0000-0002-1791-0161
Jensen PakPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA.ORCID 0000-0002-4455-7842
Mark LiuPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA.ORCID 0000-0002-4048-2214
Shun RaoPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA.ORCID 0000-0002-2081-6491
Al OzonoffPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA.ORCID 0000-0003-4233-5899
Ofer LevyPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA.
Simon D van HarenPrecision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA; simon.vanharen@childrens.harvard.edu.ORCID 0000-0002-1791-0161
Boston Children's Hospital · USBroad Institute · US

Funding

Transcriptomics to define biomarkers of neonatal vaccine immunogenicityU19AI118608 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI LEVY, OFER · 2017 to 2021
$24.7M
Small-molecule adjuvants to enhance the efficacy of flu vaccines in newborns and the elderly75N93019C00044 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI LEVY, OFER · 2019 to 2023
$11.0M
Dissecting the mechanism of age-specific adjuvant synergy in vitro and in vivoU01AI124284 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI LEVY, OFER · 2016 to 2020
$2.9M
NIAID NIH HHS 75N93019C00044NIAID NIH HHS HHSN272201400052CNIAID NIH HHS HHSN272201800047CNIAID NIH HHS U01 AI124284NIAID NIH HHS U19 AI118608
6 · The paper itself

Abstract

The newborn innate immune system is characterized as functionally distinct, resulting in impaired proinflammatory responses to many stimuli and a bias toward Th2 development. Although the magnitude of impairment can be partially overcome, for instance through activation of TLR7/8 in newborn dendritic cells, the newborn innate response remains distinct from that of adults. Using human in vitro modeling of newborn and adult dendritic cells, we investigated the role of extracellular and intracellular regulators in driving age-specific responses to TLR7/8 stimulation. MicroRNA expression profiling and plasma switch experiments identified Let-7g as a novel regulator of newborn innate immunity. Activation-induced expression of Let-7g in monocyte-derived dendritic cells (MoDCs) is driven by newborn plasma and reduces expression of costimulatory receptors CD86, MHC class I, and CCR7 and secretion of IFN-α and sCD40L. Conversely, an increase in secretion of the Th2-polarizing cytokine IL-12p40 is observed. Overexpression of Let-7g in adult MoDCs resulted in the same observations. Small interfering RNA-mediated ablation of Let-7g levels in newborn MoDCs resulted in an adult-like phenotype. In conclusion, this study reveals for the first time (to our knowledge) that age-specific differences in human plasma induce the microRNA Let-7g as a key mediator of the newborn innate immune phenotype. These observations shed new light on the mechanisms of immune ontogeny and may inform approaches to discover age-specific immunomodulators, such as adjuvants.

Indexed as

Adjuvants, ImmunologicAdultCytokinesDendritic CellsFetal BloodHumansImmunity, InnateInfant, NewbornLymphocyte ActivationMicroRNAsMonocytesPlasmaAdjuvants, ImmunologicCytokinesMicroRNAs

Identifiers

PMID33931496
PMCPMC11688640
OpenAlexW3159141025

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.